Pancreatic cancer
Results
Phase 3
This trial compared gemcitabine alone with gemcitabine and capecitabine (Xeloda) for advanced pancreatic cancer. This trial was supported by Cancer Research UK.
Unfortunately, most people with pancreatic cancer cannot have surgery to cure their cancer because it is too advanced when it is diagnosed. Doctors believe that giving chemotherapy helps patients by improving symptoms.
Doctors often use a chemotherapy drug called gemcitabine. In this trial, they wanted to see if having capecitabine chemotherapy tablets alongside gemcitabine helped.
The aim of the trial was to see if having gemcitabine and capecitabine together is better than having gemcitabine alone for advanced cancer of the pancreas.
Recruitment start: 20 May 2002
Recruitment end: 18 January 2005
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr D Cunningham
Professor J Neoptolemos
Janet Dunn
Cancer Research UK
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/01/008.
Last reviewed: 23 November 2015
CRUK internal database number: 106